Stock HANSA BIOPHARMA AB
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Analyst Reco. Hansa Biopharma AB Nasdaq Stockholm

Equities

SE0002148817

Real-time Estimate Cboe Europe
Other stock markets
 09:22:49 2024-04-29 am EDT 		5-day change 1st Jan Change
28.5 SEK -82.55% Intraday chart for Hansa Biopharma AB -5.78% -38.73%
Apr. 18 Transcript : Hansa Biopharma AB, Q1 2024 Earnings Call, Apr 18, 2024
Apr. 18 Hansa Biopharma AB Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Analyst Reco.

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Hansa Biopharma's Follow-up Study Shows High Survival Rate for Imlifidase-enabled Kidney Transplant Patients
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. HNSA Stock
  4. Stock
  5. News Hansa Biopharma AB
  6. Analyst Reco.